News
COSM
0.3359
+6.84%
0.0215
Cosmos Health sees revenue of about $54.3M for the nine months ended Sept 30
Seeking Alpha · 2d ago
Cosmos Health Sees Q3 Sales $17.400M vs $20.886M Est
Benzinga · 2d ago
Cosmos Health FY2026 Revenue expected to be more than $90.000M vs $84.300M Est
Benzinga · 2d ago
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
Barchart · 2d ago
Weekly Report: what happened at COSM last week (0928-1002)?
Weekly Report · 4d ago
Cosmos Health’s CosmoFarm reaches annualized revenue above $60M
TipRanks · 09/29 13:45
Cosmos Health’s CosmoFarm Reports Q2 Revenue Of Over $15M, $60M Annualized Run Rate; Says Robotics, Automation And AI-Enabled Systems Across Procurement, Inventory And Order Execution, With Capacity That Could Support A Further $40M Or More In Annual Revenue, Which Would Provide Infrastructure For Annualized Revenue Above $100M
Benzinga · 09/29 13:34
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue
Barchart · 09/29 08:30
Cosmos Health climbs as CMO pipeline surpasses $20M in implied revenue
Seeking Alpha · 09/28 15:29
Cosmos’ contract manufacturing division surpasses $20M in implied revenue
TipRanks · 09/28 12:36
Cosmos Health's Cana Laboratories Subsidiary Achieves Over $20M In Revenue
Benzinga · 09/28 12:04
Weekly Report: what happened at COSM last week (0921-0925)?
Weekly Report · 09/28 09:17
Weekly Report: what happened at COSM last week (0914-0918)?
Weekly Report · 09/21 09:17
Cosmos Health secures five-year contract manufacturing agreement
TipRanks · 09/15 14:40
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
Barchart · 09/15 09:30
Weekly Report: what happened at COSM last week (0907-0911)?
Weekly Report · 09/14 09:18
Cosmos Health secures five-year contract manufacturing agreement
TipRanks · 09/11 15:20
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units
Barchart · 09/11 10:10
Cosmos Health launches C-ScrubVet in the UK
TipRanks · 09/09 13:35
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market
Barchart · 09/09 08:30
More
Webull provides a variety of real-time COSM stock news. You can receive the latest news about Cosmos Health Inc. through multiple platforms. This information may help you make smarter investment decisions.
About COSM
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.